Brief: ReShape Lifesciences Reports Q1 Financial Results And Provides Corporate Update
May 23 (Reuters) - ReShape Lifesciences Inc RSLS.O :
* RESHAPE LIFESCIENCES™ REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q1 REVENUE $2.4 MILLION
* QTRLY LOSS PER SHARE $0.44
* CASH AND CASH EQUIVALENTS WERE $15.5 MILLION AS OF MARCH
31,
2022
Source text for Eikon: ID:nGNXb01cPK
Further company coverage: RSLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vyome Holdings
See all newsBrief: Vyome - Appoints Jerry Leonard As CFO On August 27, 2026 - SEC Filing
Biopharma firm Vyome Holdings posts Q2 net loss
Vyome Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Vyome Holdings Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity